KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cameco (CCJ) Liabilities and Shareholders Equity (2016 - 2025)

Cameco's Liabilities and Shareholders Equity history spans 10 years, with the latest figure at $7.4 billion for Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity rose 4.16% year-over-year to $7.4 billion; the TTM value through Dec 2025 reached $28.1 billion, up 5.33%, while the annual FY2025 figure was $7.4 billion, 4.16% up from the prior year.
  • Liabilities and Shareholders Equity reached $7.4 billion in Q4 2025 per CCJ's latest filing, up from $7.1 billion in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $7.4 billion in Q4 2025 to a low of $6.0 billion in Q4 2021.
  • Average Liabilities and Shareholders Equity over 5 years is $6.8 billion, with a median of $7.1 billion recorded in 2024.
  • Peak YoY movement for Liabilities and Shareholders Equity: rose 14.73% in 2023, then fell 2.81% in 2024.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $6.0 billion in 2021, then grew by 6.63% to $6.4 billion in 2022, then grew by 14.73% to $7.3 billion in 2023, then dropped by 2.81% to $7.1 billion in 2024, then grew by 4.16% to $7.4 billion in 2025.
  • Per Business Quant, the three most recent readings for CCJ's Liabilities and Shareholders Equity are $7.4 billion (Q4 2025), $7.1 billion (Q4 2024), and $7.3 billion (Q4 2023).